Pixium Vision SA Aktie

Kaufen

Verkaufen

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

WKNA116CC

ISINFR0011950641

SymbolPXMVF

Pixium Vision SA Aktien News

Sortieren:Datum Meistgelesen

02.02.24GlobeNewswirePixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings

17.01.24GlobeNewswirePostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024

17.01.24GlobeNewswirePostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings

18.12.23GlobeNewswireDecision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024

04.12.23GlobeNewswireCommercial Court hearing to examine the takeover offer scheduled for December 18, 2023

20.11.23GlobeNewswireUpdate on the receivership proceedings: submission of a takeover offer to the court-appointed administrators

14.11.23GlobeNewswirePixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD

13.11.23GlobeNewswirePixium Vision announces the conversion of the safeguard proceedings into receivership

26.10.23GlobeNewswirePixium Vision announces its financial results for H1 2023 and provides update

18.10.23GlobeNewswirePixium Vision announces the launch of a process to find buyers

09.10.23GlobeNewswirePixium Vision announces the opening of safeguard proceedings

20.09.23GlobeNewswirePixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion

28.07.23GlobeNewswirePixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares

11.07.23GlobeNewswirePixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility

15.06.23GlobeNewswireResults of the Annual General Shareholder Meeting as of June 13, 2023

08.06.23GlobeNewswirePixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit

24.05.23GlobeNewswireAnnual Meeting of Shareholders June 13, 2023 / Availability of preparatory documents

10.05.23GlobeNewswirePixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023

25.04.23GlobeNewswirePixium Vision announces the availability of its annual report for the financial year 2022

21.04.23GlobeNewswirePixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023

03.04.23GlobeNewswire Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD

31.03.23GlobeNewswirePixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD

17.03.23GlobeNewswireReduction of share capital due to losses by reduction of nominal value: number of shares unchanged

10.03.23GlobeNewswireResults of Extraordinary Shareholders Meeting held on March 8, 2023

28.02.23GlobeNewswireExtraordinary Shareholder Meeting of March 8, 2023: Notice of publication of the preparatory documents

16.02.23GlobeNewswireSecond convening of the Extraordinary Shareholder Meeting on March 8, 2023

15.02.23GlobeNewswirePixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO

14.02.23GlobeNewswirePixium Vision announces its cash position at 31 December 2022 and provides an update on its activities

13.02.23GlobeNewswirePixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO

15.11.22GlobeNewswirePixium Vision announces participation in investor conferences in November and December 2022

11.10.22GlobeNewswirePixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering

04.10.22GlobeNewswirePixium Vision announces participation in investor conferences and events in October 2022

21.09.22GlobeNewswirePixium Vision to host open house event for investors on October 13th 2022 from 5 pm

19.09.22GlobeNewswirePixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

13.09.22GlobeNewswirePixium Vision announces implantation of first patient in Italy in Prima System European pivotal trial PRIMAvera

06.09.22GlobeNewswirePixium Vision announces participation in upcoming investor conferences in September 2022

29.08.22GlobeNewswirePixium Vision announces participation in upcoming scientific conferences in September 2022

11.08.22GlobeNewswirePixium Vision to attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022

03.08.22GlobeNewswirePixium Vision announces regulatory approval of remote rehabilitation system for patients in clinical trials

26.07.22GlobeNewswirePixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera

Pixium Vision SA News

Pixium Vision SA News: auf dieser Seite finden Sie alle Pixium Vision SA News und Nachrichten zur Pixium Vision SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pixium Vision SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pixium Vision SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.